Latest stories on PBLS
Parabilis Medicines: Bullish On Zolucatetide's Broad Oncology Potential
Seeking Alpha64 · neutralanalyst
Parabilis Medicines, Inc. (PBLS) Discusses Updated Zolucatetide Data in Desmoid Tumors and Phase III Path - Slideshow
Seeking Alpha58 · neutralproduct/pr
Parabilis Medicines announces safety, efficacy data for zolucatetide
The Fly63 · neutralproduct/pr
H.C. Wainwright initiates Parabilis Medicines stock coverage with buy rating
Investing.com Analyst Ratings63 · neutralanalyst
Parabilis Medicines initiated with a Buy at H.C. Wainwright
The Fly64 · neutralanalyst
Parabilis: $1B+ Rare-Disease Foundation Leaves The Big Oncology Pipeline For Free
Seeking Alpha64 · neutralanalyst
Why Is Parabilis Medicines Stock (PBLS) Up 11% Today?
TipRanks64 · neutralgeneral
Regeneron-backed Parabilis rises ahead of trial data for lead asset
Seeking Alpha64 · neutralproduct/pr
PBLS jumps as Parabilis tees up updated zolucatetide data for ESMO 2026—with a June 22 cutoff and a Phase 3 dosing aim
October 19, 2026
MarketChameleon64 · neutralproduct/pr
PBLS Sets an October 24 Stage for Updated Zolucatetide Data in Desmoid Tumors at ESMO 2026
October 19, 2026
MarketChameleon58 · neutralproduct/pr
Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026
Business Insider58 · neutralproduct/pr
Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026
GlobeNewswire58 · neutralproduct/pr
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
GlobeNewswire58 · neutralproduct/pr
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
Business Insider58 · neutralproduct/pr
Parabilis Medicines rises 6.3%
The Fly58 · neutralgeneral
Sixty Degree Capital Extends Its Track Record as Five Portfolio Companies Enter the Public Markets in 2026
PR Newswire67 · bullishgeneral
Parabilis Medicines falls -12.5%
The Fly38 · neutralgeneral
Parabilis Medicines, Inc. (PBLS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Parabilis Medicines, Inc. (PBLS) files 8-K
SEC 8-K50 · neutralgeneral
PBLS Competitors for Parabilis Medicines Stock
Barchart50 · neutralgeneral
Parabilis Medicines, Inc. (PBLS) files 8-K
SEC 8-K50 · neutralgeneral
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
StockTitan56 · neutralgeneral